Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning - Full Text View

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

This study is currently recruiting participants.
Verified by Louisiana State University, December 2007

Sponsored by:	Louisiana State University
Information provided by:	Louisiana State University
ClinicalTrials.gov Identifier:	NCT00596180

Purpose

That SPECT brain imaging tracks and is consistent with clinical history and physical exam as well as cognitive testing.

Condition	Intervention	Phase
Non-Acute Carbon Monoxide Poisoning	Drug: HBOT	Phase I

MedlinePlus related topics:

Carbon Monoxide Poisoning Poisoning

ChemIDplus related topics:

Carbon monoxide

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Open Label, Single Group Assignment, Efficacy Study

Official Title:	Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Further study details as provided by Louisiana State University:

Primary Outcome Measures:

SPECT brain imaging [ Time Frame: after completion of HBOT ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

clinical history and physical exam [ Time Frame: after completion of HBOT ] [ Designated as safety issue: No ]

Estimated Enrollment:	30
Study Start Date:	January 2007
Estimated Study Completion Date:	December 2008
Estimated Primary Completion Date:	December 2008 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
1: Experimental HBOT	Drug: HBOT total body exposure to greater than atmospheric pressure oxygen

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Adults and children with non-acute carbon monoxide poisoning who underwent SPECT brain imaging as part of their evaluation and treatment

Exclusion Criteria:

None.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00596180

Contacts


Contact: Paul G Harch, M.D.	504-366-1445	paulharchmd@aol.com

Locations


United States, Louisiana
	Family Physicians Center	Recruiting
	Marrero, Louisiana, United States, 70072
	Contact: Paul G Harch, M.D. 504-366-1445 paulharchmd@aol.com
	Principal Investigator: Paul G Harch, M.D.

Sponsors and Collaborators

Louisiana State University

Investigators


Principal Investigator:	Paul G Harch, M.D.	LSU School of Medicine

More Information

Responsible Party:	LSU School of Medicine ( Paul G. Harch, M.D. )
Study ID Numbers:	LSU IRB #6626
First Received:	January 4, 2008
Last Updated:	January 4, 2008
ClinicalTrials.gov Identifier:	NCT00596180
Health Authority:	United States: Institutional Review Board

Keywords provided by Louisiana State University:

carbon monoxide poisoning

brain injury

Study placed in the following topic categories:

Carbon Monoxide Poisoning

Poisoning

Carbon Monoxide

Disorders of Environmental Origin

Brain Injuries

Additional relevant MeSH terms:

Antimetabolites

Molecular Mechanisms of Pharmacological Action

Gas Poisoning

Pharmacologic Actions

ClinicalTrials.gov processed this record on August 28, 2008